NasdaqGS:DXCMMedical Equipment
DexCom (NasdaqGS:DXCM) Announces US$750M Buyback and Reiterates 2025 Earnings Guidance
DexCom (NasdaqGS:DXCM) recently announced a $750 million share buyback program and reaffirmed its revenue growth guidance of 14% for 2025, coinciding with its earnings report for the first quarter showing increased sales but decreased net income. In the past month, the company's share price saw a 4% rise, bolstered by broader market gains, as the S&P 500 extended a notable winning streak and investor sentiment was uplifted by strong employment data. Despite fluctuations due to Dexcom's mixed...